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Many in vivo trials have evaluated the effects of grape products on different CVD risk factors.
Most published studies have dealt with some specific aspects of mechanisms of grape flavonoid
action or have focused only on one product, such as wine. The aim of the present paper is to
review trials dealing with grape products and CVD published during the last 13 years (seventy-
five trials). Polyphenols, alcohol and dietary fibre are the main constituents of the tested products.
In animal and human studies, grape products have been shown to produce hypotensive,
hypolipidaemic and anti-atherosclerotic effects, and also to improve antioxidant status as
measured in terms of plasma antioxidant capacity, oxidation biomarkers, antioxidant compounds
or antioxidant enzymes. Differences in the design of the studies and in the composition of the
tested products (not always provided) could explain the different results of these studies.
Grapes: Wine: Grape products: Cardiovascular disease
Introduction
CVD continues to be a leading cause of morbidity and
mortality among adults in Western countries. Cigarette
smoking, high blood pressure, high serum total cholesterol
and LDL-cholesterol, low serum HDL-cholesterol, diabetes
mellitus and advanced age are considered the main risk
factors for CVD(1,2).
A large number of epidemiological studies have
associated a diet rich in fruits and vegetables with a
reduction in CVD risk factors(3). This is presumably due to
the presence in plant foods and certain beverages of a variety
of compounds including different kinds of antioxidants,
such as vitamin C, vitamin E, polyphenols and carotenoids.
Polyphenols in particular have been associated with a
reduction of the risk of different diseases in several
epidemiological studies(4).
The French paradox(5), i.e. the low prevalence of CVD in
certain French regions with a high intake of saturated fats,
has been put down to the consumption of red wine.
This effect has been attributed mainly to the presence of
polyphenols, a large group of compounds present in plant
foods and beverages that have demonstrated a strong in vitro
antioxidant capacity due to their ability to scavenge free
radicals and to chelate metals(6). Ethanol can also improve
the bioavailability of polyphenols, as well as playing a
specific cardioprotective role.
The possible benefits of grape and wine consumption in
relation to CVD have prompted researchers to conduct
many in vivo trials to study the effects of grape products
(grape juice, grape seed, grape skin, polyphenol-rich
extracts) on different CVD risk factors. Most reviews have
focused only on wine(7) or have dealt with some specific
aspects of grape and wine flavonoids’ mechanisms of action,
such as their effects on endothelial dysfunction(8). However,
no paper has systematically discussed the in vivo trials
performed during recent years in relation to grape products
and CVD risk.
The aim of the present paper is to review the trials
published during the last 13 years (thirty-four in animals and
forty-one in human subjects) examining the effects of
supplementation with grape products on CVD risk factors.
Grape products used in clinical trials
Clinical trials have evaluated the in vivo effects of grapes,
wine, grape skin, grape seeds, grape pomace and grape
polyphenol extracts. Table 1 summarises the main
compositional characteristics of these products.
Grapes (Vitis vinifera L.) contain high concentrations
of polyphenols, especially flavonoids. The amount and
composition of biologically active compounds present in
grapes and grape products vary greatly according to the
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species, variety, maturity, seasonal conditions, production
area and yield of the fruit(9). The main grape polyphenols
are anthocyanins in red grapes and flavan-3-ols in the case
of white grapes; red grapes contain more total polyphenols
than white grapes. Grape seeds and skins are also an
important dietary source of flavonoids, and seeds contain
significant amounts of proanthocyanidins or condensed
tannins. The composition of the seeds is much more diverse
than that of the skins(9). Some in vivo studies have dealt with
the effects of the intake of the original grapes after freeze-
drying(10,11). Other studies have investigated the effects of
the intake of grape seeds or grape peels separately(12 – 14).
The most common commercial product derived from
grapes is wine, a moderately alcoholic drink made by
fermentation of juice extracted from fresh, ripe grapes.
The processing of grapes to yield wine transforms the
polyphenols present in grapes, and as a result the main
polyphenols in wine are flavan-3-ols, flavan-3,4-diols,
anthocyanins and anthocyanidins, flavonols, flavones,
condensed tannins and a characteristic biologically active
compound, resveratrol – a stilbene whose concentration can
range from 1·5 to 3 mg/l(9,15). Consequently, given the
polyphenol contents of the raw material, red wine exhibits a
much higher phenolic content than white wine. Several
in vivo studies have examined the effects of the intake of
red(16 – 19) and white(20,21) wine.
There are some alcohol-free products derived from wine.
The most common of these is grape juice, which has been
used in several in vivo studies(22 – 24). Grape juice differs
little in composition from grapes except that it lacks dietary
fibre and oil. Its characteristic polyphenols include ellagic
acid, an acid hydrolytic product of ellagitannins(9). Also, for
some intervention studies dealcoholised red wine has been
prepared(12,25) in order to consider the possible effect of
ethanol on the bioavailability of polyphenols and to
differentiate the positive effects on CVD due to polyphenols
and those due to ethanol. To the authors’ knowledge, no
in vivo study has considered solely the possible positive
effects of dealcoholised white wine.
Because grape juice has a high energy value due to its
high sugar content, other products derived from grapes have
been studied. The most common of these are products
derived from grape pomace, a by-product of wine-making
consisting of pressed skins, seeds and stems. Traditionally,
grape pomace was used as a source of different products,
such as ethanol, tartrates, citric acid, grape seed oil, grape
seed tannins, hydrocolloids and anthocyanins(9); however,
with growing interest in the beneficial effects of grapes over
the last few years, grape pomace-derived products have
come to be used in intervention studies(26,27) because of its
high concentrations of phenolic compounds and dietary
fibre, another beneficial component(28). Specific prep-
arations of grape products rich in both dietary fibre and
polyphenols have also been used to check the possible
combined effect of these compounds(29).
Finally, several commercial products have been devel-
oped during the last few years, mainly in the form of pills.
A recent study(30) compared the antioxidant capacity of up
to thirteen commercial products derived from grape skins,
grape pomace and grape leaves; most of these products are
supplied in solid form, although some of them came in the
form of liquid concentrates and syrups. Anthocyanidin-3-
glucosides presented the largest concentration, although the
profiles of the ingredients derived from skin and those
derived from leaves were different. However, in this and in
other studies(31) it has been noted that the polyphenol
content of these supplements differs significantly, which
means that the biological activities derived from them will
be different. Some of them have been employed in in vivo
studies(32 – 33).
In short, different compounds may contribute to the
observed effects depending on the tested grape product:
polyphenols and ethanol in wine, polyphenols and sugar in
grape juice, polyphenols and dietary fibre in grape seeds and
grape skins, or just polyphenols in extracts(9,15,28,30,34).
Trials reviewed
Table 2 summarises the selected in vivo studies performed
on animals. Thirty-four articles have been considered. They
include studies on supplementation with freeze-dried
grapes, grape pomace, grape peel, grape seed, polyphenols
from grapes, polyphenols from grape seed, extracts from
white grape seed, extracts from red grape seed, a grape
product rich in both dietary fibre and polyphenols, grape
juice, red and white wine, dealcoholised red wine, red wine
powder and red wine extracts. The studies were performed
on rats, apoE-deficient mice, rabbits (normal and Watanabe
heritable hyperlipidaemic), hamsters, gerbils, ovari-
ectomised guinea-pigs, chickens, monkeys and dogs. The
number of animals in each study was between twenty and
180, with an average of fifty-three subjects. The duration of
Table 1. Main compositional characteristics of grapes and polyphenol-rich derived products(9,14,28,30,34)
Product Main polyphenols Other components
Grapes Anthocyanidins in red grapes, flavan-3-ols in white grapes Sugar (16% fresh matter)
Dietary fibre (about 1% fresh matter)
Wine Flavan-3-ols, flavan-3,4-diols, anthocyanins, flavones,
condensed tannins, resveratrol. Content is higher
in red wine than in white wine
Ethanol (3·5–13·5%)
Grape juice Anthocyanins in red grape juice, flavan-3-ols in white
grape juice, ellagic acid
Sugar (16%)
Grape skin Prodelphinidins Dietary fibre (. 75%)
Grape seeds Procyanidins Dietary fibre (. 75%)
Grape pomace Anthocyanins, anthocyanin-derived pigments Dietary fibre (. 60%)
Polyphenol extract Anthocyanidin-3-glucosides Main components are polyphenols; others
are usually non-identified
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Table 2. Published trials in animals on effects of grapes, wine and derived products on CVD risk factors in animals*
Reference
Species and number
of animals Duration Product and intake
Cui et al. (2002)(10) Rats Control treatment or freeze-dried grapes at different concentrations: 50, 100
and 200mg/kg weight per d
Zern et al. (2003)(11) Twenty-three
ovariectomised
guinea-pigs
12 weeks Control treatment or diet with 10% freeze-dried grapes, 6% dietary fibre and
0·5% total polyphenols. Intake ad libitum
Ruf et al. (1995)(12) 144 rats 4 months Series 1: tap water, ethanol 6%, red wine diluted in water (6% ethanol) or white
wine diluted in water (6% ethanol)
Series 2: ethanol 6%, red wine diluted in water (6% ethanol), ethanol 6% with
0·2% glycerol or ethanol 6% with 0·025% grape seed extract
Series 3: ethanol 6%, red wine diluted in water (6% ethanol) or red wine extract
added to ethanol 6%
Series 4: water, red wine diluted in water (6% ethanol) with the same content in
glycerol as dealcoholised red wine or dealcoholised red wine
Martı´n-Carro´n
et al. (2000)(13)
Twenty-four rats 4 weeks Diet with and without cholesterol, two groups in each: control treatment or
product from grapes rich in polyphenols (1·63%) and fibre (50%) (10% diet)
Martı´n-Carro´n
et al. (2000)(13)
Eighty rats 42 d Diet with and without cholesterol, three groups in each: control with cellulose,
white grape peel or white grape seed (all the groups with 54–59% dietary fibre)
Falchi et al. (2006)(14) Rats 30 d Grape seed extract (0·18–0·33% total polyphenols fresh matter), grape flesh
extract (0·03–0·04% total polyphenols fresh matter) or water
Osman et al. (1998)(22) Five monkeys 1 week Orange juice, grape juice or grapefruit juice (5ml/kg per d of each)
Cross-over design
Shanmuganayagam
et al. (2007)(23)
Twenty rabbits 48 d Diet with cholesterol in all groups. Water with sugar or grape juice with
1·97 g total polyphenols/l
Bobek et al. (1998)(26) Eighty rats 10 weeks Diet with cholesterol supplemented with: cellulose, grape pomace, apple
pomace or tomato pomace
Diebolt et al. (2001)(40) Twenty-four rats 1 week Product with glucose 5% or two different extracts of polyphenols from red
wine (in all cases, 20mg/kg weight per d)
Bernatova et al. (2002)(41) Forty-eight rats After taking L-NAME for
3 weeks, three groups:
Control treatment or red wine polyphenols
Six were killed
Eighteen were divided into
three groups and came
back to their usual diet
after 1, 2 and 3 weeks
Eighteen were divided into
three groups and were
supplemented for 1, 2
and 3 weeks
Soares de Moura
et al. (2002)(42)
Rats 28 d in hypertensive rats
providing L-NAME and
13d in hypertensive rats
providing deoxycorticosterone
Control treatment or grape peel with 5·5% total polyphenols
(100mg/kg weight per d)
Al-Awwadi et al. (2004)(43) Forty-five rats 6 weeks Control treatment, diet rich in fructose, diet rich in fructose and red wine extract
in water with 47·1% total polyphenols, diet rich in fructose and ethanol 10%
or diet rich in fructose and red wine extract in ethanol with 47·1% total
polyphenols (all supplementations with 10ml/kg weight per d)
Ranaivo et al. (2004)(44) Rats 1 week Supplementation by intragastric administration: control with glucose 5%,
RWPC (20mg/kg weight per d), L-NAME or RWPC and L-NAME
Wollney et al. (1999)(50) Rats 10 d Red wine with 12% ethanol, dealcoholised red wine, ethanol solution (12%)
or white wine
Vinson et al. (2001)(58) Hamsters 10 weeks Water, ethanol, red wine, dealcoholised red wine or grape juice
J.
P
e´rez-Jim
e´n
ez
an
d
F
.
S
au
ra-C
alix
to
1
6
0
Nutrition Research Reviews
Auger et al. (2002)(59) Thirty-two hamsters 8 weeks Atherogenic diet supplemented with: 7·14ml water/kg weight per d, 7·14ml
ethanol/kg weight per d, diet with 47·1% red wine polyphenols in water or
diet with 47·1% red wine polyphenols in ethanol
Auger et al. (2004)(60) Forty hamsters 12 weeks Diet with cholesterol in all groups. Control treatment, extract from white grape
seed rich in procyanidins, extract from white and red grape seeds rich in
procyanidins or extract from grape seeds (in all supplemented groups,
7·14ml/kg weight per d)
Auger et al. (2005)(61) Hamsters 12 weeks Atherogenic diet in all groups. Control treatment, ethanol, red wine (570mg total
polyphenols/l) or enriched white wine (1425mg total polyphenols/l)
Cestaro et al. (1996)(62) Forty rats 4 weeks Red wine (12% ethanol), dealcoholised red wine with sugar, ethanol 12% or water
with sugar
Yamakoshi et al.(1999)(63) Thirty-eight rabbits 8 weeks Control treatment, diet with cholesterol, diet with cholesterol and 1% extracts from
grapes, diet with cholesterol and 0·1% extracts from grapes or diet with
cholesterol and Probucol
Araya et al. (2001)(64) Eighty rats 10 weeks Water, ethanol 12·5%, red wine with 12·5% ethanol or dealcoholised red wine
Pal et al. (2004)(73) Twenty rats 5 weeks Control with cellulose or grape product rich in both dietary fibre and polyphenols
with 4·7% total polyphenols (50mg/kg weight per d)
Hayek et al. (1997)(70) Forty apoE-deficient mice 6 weeks Ethanol 1·1%, 0·5ml red wine/d (1·1% ethanol and 50mg catechin), 50mg
catechin/d in ethanol 1·1% or 50mg quercetin/d in ethanol 1·1%
Nakamura & Tonogai
(2002)(72)
Rats 28 d or 36 d (two
experiments)
Diet with and without cholesterol and with different doses of grape seed polyphenols
Frederiksen
et al. (2007)(83)
Twenty-seven Watanabe
heritable hyperlipidaemic
rabbits
15 weeks Semi-synthetic diet or semi-synthetic diet with 2·6% extract from red grape skin
and seed
Waddington
et al. (2004)(84)
100 apoE-deficient
mice and fifty control mice
15 weeks Water in controls, water in apoE-deficient mice or red wine in apoE-deficient mice
(0·6mg polyphenols/d)
Benteon et al. (2001)(85) Eighty-four
apoE-deficient mice
21 weeks Water, red wine (ethanol 6%), ethanol 6% or red wine powder
Stocker & O’Halloran
(2004)(86)
Eighty-seven
apoE-deficient mice
24 weeks Water or dealcoholised red wine
Xia et al. (1998)(87) Rats 2 months Control, ethanol, polyphenols from grapes and ethanol or polyphenols from grapes
Rodrigo et al. (2002)(93) Eighty rats 10 weeks Red wine, dealcoholised red wine, water, ethanol or ethanol 12·5%
Gon˜i et al. (2007)(95) 120 chickens 3 weeks Vitamin E (200mg/kg weight per d), red grape pomace (5mg/kg weight per d) or
control with cellulose (30mg/kg weight per d)
Brenes et al. (2008)(96) 180 chickens 3 weeks Control, vitamin E (200mg/kg weight per d), red grape pomace concentrate
(15mg/kg weight per d), red grape pomace concentrate (30mg/kg weight per d)
or red grape pomace concentrate (60mg/kg weight per d)
Roig et al. (1999)(101) Fifteen rats 45 d or 6 months
(two experiments)
Water, ethanol 13·5% or red wine with 13·5% ethanol. Intake ad libitum
Wang et al. (2005)(102) Fifty gerbils 2 months Control treatment or freeze-dried grapes (5 g/kg diet or 50 g/kg diet)
L-NAME, N-nitro-L-arginine-methyl ester; RWPC, red wine polyphenols concentrate.
*When not indicated expressly, grapes are red grapes and wine is red wine.
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the studies was between 1 week and 6 months, with an
average of 2 months.
Table 3 summarises the selected in vivo studies performed
on human subjects. Forty-one articles have been considered.
They include studies on supplementation with freeze-dried
grapes, grape peel, grape seed, polyphenols from grapes,
polyphenols from grape seed, grape juice, concentrated
grape juice, red and white wine, dealcoholised red wine and
red wine polyphenol extracts. The studies include healthy
subjects, subjects with coronary artery disease, type 2
diabetic patients, pre- and postmenopausal women, hyperch-
olesterolaemic subjects, hypertensive subjects, men with
stable IHD and haemodialysed subjects. The number of
participants in each study was between eight and sixty-nine,
with an average of twenty-four subjects. The duration of the
studies was between 1 and 16 weeks, with an average of 25 d,
plus eight studies which were based on an acute intake.
Effects on blood pressure: endothelial function
The US National High Blood Pressure Education program
estimates that a reduction of 5 mmHg in systolic blood
pressure (SBP) translates into a 14 % reduction in deaths by
stroke, a 9 % reduction in deaths by heart disease and a 7 %
reduction in overall mortality(35). This has generated an
interest in the search for new bioactive dietary compounds
that can reduce blood pressure, among them polyphenols.
However, when considering the effects of grape products
on blood pressure, the ethanol content of red wine, one of
the main grape products, should not be disregarded. It is
well known that there is a linear relationship between
alcohol intake and blood pressure(36). Although several
epidemiological studies have suggested that beer and spirits
consumption may be associated with higher blood pressure
(particularly SBP) than wine consumption(37,38), an in vivo
trial(39) showed that daily consumption of 40 g alcohol as
either red wine or beer for 4 weeks resulted in similar
increases in SBP and heart rate. Therefore, studies on the
effects of grape products on blood pressure should be
focused more on grape products lacking ethanol.
All the reviewed studies on animals dealing with the
effects of grape polyphenols on blood pressure showed a
hypotensive effect of them. Grape skin extract, red wine
polyphenols and red wine extract significantly reduced blood
pressure (in several cases, both SBP and diastolic blood
pressure) in normotensive and hypertensive rats, where
hypertension was induced by N-nitro-L-arginine-methyl
ester (L-NAME) or by deoxycorticosterone acetate(40 – 44).
In the case of human subjects, a significant reduction in
SBP and diastolic blood pressure was observed in
hypertensive or coronary artery disease subjects after the
intake of grape juice(45). Also, the intake of a grape product
rich in both dietary fibre and polyphenols by normotensive
subjects for 16 weeks led to a non-significant decrease in SBP
and diastolic blood pressure(30). This is an interesting result,
since assays on the effects of supplementation on blood
pressure are usually performed on hypertensive subjects, and
these might be expected to present a more marked effect if
administered this product, which is rich in both polyphenols
and dietary fibre. However, another study did not find any
effect of dealcoholised red wine on blood pressure(39). Only
one of the reviewed trials found that grape polyphenols had
adverse effects on blood pressure; there, increased blood
pressure was observed in hypertensive subjects when
polyphenols were combined with vitamin C(46).
As to mechanisms that would explain the generally
observed hypotensive effect of polyphenols, it has been
suggested that they promote the release by the vascular
endothelium of NO, a compound with vasorelaxing and
anti-aggregating effects and that in the long term induces the
expression of protective genes for the cardiovascular
system(40,47). It has also been proposed that wine may
regulate the endothelial NO synthase gene in endothelial
cells, through transcriptional and post-transcriptional
factors(48).
These hypotheses have only been partially proven. In an
ex-vivo experiment with aortic rings from rats incubated
with red grape polyphenols, there was a two-fold increase in
the NO-Fe(diethyldithiocarbamate)2 electron paramagnetic
resonance, which indicates the generation of NO; this NO
production was completely prevented by the NO synthase
inhibitor L-NAME(49). Similarly, after supplementing rats
with red wine and observing an anti-thrombotic effect(50),
the effects produced by red wine were prevented by
L-NAME, indicating the involvement of NO in this process.
Moreover, the effects of L-NAME could be reverted by
L-arginine, the precursor of NO synthesis in vascular
endothelium but not by its stereoisomer, D-arginine. In
human subjects, although an acute intake of polyphenols did
not significantly increase NO production(51), the supplemen-
tation to healthy volunteers with grape juice for 14 d led to a
significant increase in platelet-derived NO production (from
3·5 (SEM 1·2) to 6·0 (SEM 1·5) pmol/108 platelets(52)).
Another parameter that has been studied to determine the
effect of grape polyphenols on endothelial function has been
the determination of effects on vasodilatation and,
particularly, on flow-mediated dilatation of the brachial
artery, which is considered to be an early marker of
alterations in endothelial function. In studies in animals, red
wine polyphenols induced endothelium-dependent relax-
ation in rat aorta(49), red wine and dealcoholised red
wine induced vasodilatation in isolated vessels from rats(53)
and grape skin extract had a vasodilator effect on the
mesenteric cardiovascular bed of rats(42). In human subjects,
an improvement in endothelium-dependent vasodilatation
has been reported after the acute intake of white wine or red
wine with a meal by subjects with IHD(54); also it has been
observed that an acute intake of red grape polyphenol
extract, red wine or dealcoholised red wine cause an
increase in flow-mediated dilatation, peaking at
60 min(54,55). Nevertheless, in another study(53) red wine,
but not polyphenols from red wine, produced an enhance-
ment of endothelial response, despite a similar catechin
concentration in both products. Intake of grape juice or
grape seed extract for 2–3 weeks also caused a significant
increase in flow-mediated dilatation, compared with the
control group(56,57). Interestingly, in one of these studies(57),
the addition of quercetin to the grape seed extract nullified
this effect, indicating maybe that the provided amount of
antioxidants was excessive, thus becoming pro-oxidants.
Also, grape polyphenols may have a reducing effect in
cardiac fibrosis, a process occurring in cases of hypertension
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Table 3. Published trials on effects of grapes, wine and derived products on CVD risk factors in human subjects*
Reference Participants Duration Product and intake
Badia et al. (2004)(16) Eight healthy men 2 weeks Red wine with 12·5% ethanol (320ml/d) or gin (100ml/d) (in both cases, 30 g ethanol/d)
Sacanella et al. (2007)(17) Thirty-five healthy women 4 weeks Red wine with 13·5% ethanol and 1·9 g total polyphenols/l or white wine with 13% ethanol
and 0·31 g total polyphenols/l
Agewall et al. (2000)(18) Twelve healthy subjects Acute intake Red wine with 1·9 g total polyphenols/l and 12·5% ethanol or dealcoholised red wine with
1·1 g total polyphenols/l (250ml in all groups)
Cross-over design
Naissides et al. (2004)(19) Seventeen postmenopausal women Acute intake Dealcoholised red wine with 2·2 g total polyphenols/l, white wine with 2·2 g total
polyphenols/l or water
Cross-over design
Williams et al. (2004)(20) Fourteen men with stable IHD Acute intake Red wine with 13·5% ethanol and 1·2 g total polyphenols/l, white wine with 13% ethanol
and 0·2 g total polyphenols/l or non-alcoholic drink without polyphenols
Cross-over design
Pignatelli et al. (2006)(21) Twenty healthy subjects 3 weeks Red wine with 12·5% ethanol and 1·2 g total polyphenols/l or white wine with 12·5%
ethanol and 0·18 g total polyphenols/l
Castilla et al. (2008)(24) Thirty-two haemodialysed patients 2 weeks Red grape concentrate (100ml/d ¼ 600mg total polyphenols/d), 800 IU (20mg) vitamin
E/d or both
De Rijke et al. (1996)(25) Twenty-four healthy subjects 2 weeks, then
4 weeks
with different
treatments
After 2 weeks with white wine: 4 weeks with white wine (3·5% ethanol) or partially
dealcoholised red wine (3·5% ethanol) (550ml/d in all groups)
Pe´rez-Jime´nez et al. (2008)(29) Forty-three non-smokers, including
normocholesterolaemic and
hypercholesterolaemic subjects
16 weeks Control treatment or grape product rich in both dietary fibre and polyphenols (7·5 g/d),
with 4·93% total polyphenols and 73·5% dietary fibre
Carbonneau et al. (1997)(32) Twenty healthy men 14 d Six daily pills containing an extract of red wine polyphenols
Vinson et al. (2001)(33) Nine hypercholesterolaemic and eight
normocholesterolaemic subjects
3 weeks MegaNaturalw Gold Grape Seed Extract (600mg extract ¼ 552mg total polyphenols)
Zilkens et al. (2005)(39) Twenty-four healthy men who drank
30–60 g alcohol/d
4 weeks Red wine with 13% ethanol and 2 g total polyphenols/l (375ml/d), the same wine
dealcoholised (375ml/d), deprivation of alcohol and grapes or beer with 4·6%
ethanol (1175ml/d)
Park et al. (2004)(45) Hypertensive men 8 weeks Grape juice with 2·1 g total polyphenols/l or placebo (11ml/kg weight per d in all groups)
Ward et al. (2005)(46) Hypertensive subjects 6 weeks Vitamin C, polyphenols from red grape seeds (1 g/d), both or control
Chou et al. (2001)(47) Fifteen healthy subjects 1 week Extract from grape peel with 5% total polyphenols (600mg extract/d)
Matsuo et al. (2001)(51) Six men Acute intake Red wine, ethanol, polyphenols from red wine
Cross-over design
Freedman et al. (2001)(52) Twenty healthy volunteers 2 weeks Purple grape juice (7ml/kg weight per d)
Boban et al. (2006)(53) Nine men Acute intake Red wine, dealcoholised red wine, polyphenols from red wine, ethanol–water solution, water
Cross-over design
Whelan et al. (2004)(108) Fourteen men with stable IHD Acute intake Red wine with 13·5% ethanol and 1·2 g total polyphenols/l or white wine with 13% ethanol
and 0·2 g total polyphenols/l
Cross-over design
Hashimoto et al. (2001)(54) Nine men Acute intake Water, Japanese vodka (shochu, 0·8 g ethanol/kg weight), red wine with 0·8 g ethanol/kg
weight or dealcoholised red wine
Cross-over design
Lekakis et al. (2005)(55) Thirty men with CHD Acute intake Red grape polyphenols (600mg) or water
Stein et al. (1999)(56) Fifteen subjects with coronary
artery disease
2 weeks Grape juice (4ml/kg weight per d)
Clifton (2004)(57) Forty-three subjects with above-average
vascular risk
4 weeks Grape seed extract (2 g/d), grape seed extract (2 g/d) plus quercetin (0·5 g/d) or control
Castilla et al. (2006)(65) Thirty-eight haemodialysed and fifteen
healthy subjects
2 weeks Concentrated grape juice (100ml/d ¼ 600mg total polyphenols/d)
Cordain et al. (2000)(66) Twenty sedentary and overweight
premenopausal women
10 weeks Red wine with 13% ethanol (190ml/d) or absence of alcohol
Cross-over design
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Table 3. Continued
Reference Participants Duration Product and intake
Cacetta et al. (2001)(67) Eighteen male smokers 2 weeks Red wine with 13·3% ethanol and 1·2 g total polyphenols/l (375ml/d), white wine with
13·7% ethanol and 0·34 g total polyphenols/l (375ml/d) or dealcoholised red wine
with less than 2% ethanol and 0·9 g extractable polyphenols/l (500ml/d)
Zern et al. (2005)(68) Twenty-four premenopausal and twenty
postmenopausal women
4 weeks Placebo or freeze-dried red grapes with 3·4% dietary fibre and 5·8% total polyphenols
Cross-over design
Naissides et al. (2006)(69) Forty-five postmenopausal women with
moderate hypercholesterolaemia
6 weeks Water, red wine with 13% ethanol and 2·5 g total polyphenols/l or dealcoholised red wine
with 2·5 g total polyphenols/l (400ml/d in all groups)
Fuhrman et al. (1995)(75) Seventeen healthy men 2 weeks White wine or red wine (400ml/d in all groups)
Hansen et al. (2005)(76) Sixty-nine healthy subjects 4 weeks Red wine with 12·75% ethanol (300ml/d for men and 200ml/d for women), equivalent dose
of grape polyphenols, half the equivalent dose of grape polyphenols or placebo
Tsang et al. (2005)(77) Twenty-three healthy subjects 2 weeks Red wine 12% ethanol (375ml/d ¼ 165mg polyphenols) or control
Avellone et al. (2006)(78) Forty-eight healthy subjects 4 weeks Red wine (250ml/d)
O’Byrne et al. (2002)(80) Thirty-six healthy subjects 2 weeks Grape juice concentrate (10ml/kg weight per d) or 400 IU (268mg) RR-a-tocopherol
Keevil et al. (2000)(81) Ten healthy subjects 1 week Grape juice, grapefruit juice or orange juice (5–7·5ml/kg weight per d)
Cross-over design
Pace-Asciak et al. (1996)(82) Twenty-four healthy men 4 or 8 weeks
with
different
treatments
Series 1: 2 wash-out weeks þ4 weeks with red wine þ2 wash-out weeks þ4 weeks
with white wine
Series 2: 2 wash-out weeks þ8 weeks with enriched grape juice þ2 wash-out
weeks þ4 weeks with white wine þ2 wash-out weeks þ4 weeks with red wine
All supplementations with 375ml/d
Nidgikar et al. (1998)(88) Thirty healthy men 2 weeks Red wine with 1·6 g total polyphenols/l, white wine with 0·2 g total polyphenols/l, white wine
and 1 g polyphenols, 1 g red wine polyphenols or control drink with ethanol 10% (375ml/d
in all groups)
Cross-over design
Nidgikar et al. (1998)(88) Twenty healthy men 2 weeks Blackcurrant drink (330ml/d), 1 g red wine polyphenols, 2 g red wine polyphenols or 1000 IU
(671mg) RR-a-tocopherol
Cross-over design
Estruch et al. (2004)(89) Forty healthy subjects 4 weeks Red wine (320ml/d) or gin (100ml/d)
Van der Gaag et al. (2000)(92) Eleven healthy subjects 3 weeks Red wine, beer, spirits or mineral water (four glasses/d in all groups)
Cross-over design
Simonetti et al. (2002)(98) Ten healthy subjects 1 month Pills with procyanidins from grape seed (280mg/d)
Ceriello et al. (2001)(100) Twenty type 2 diabetic patients Acute intake Standard meal test, fasting ingestion of red wine (300ml) or meal plus red wine (300ml)
Guarda et al. (2005)(103) Twenty patients with acute
coronary syndrome
2 months Red wine (250ml/d)
Gin et al. (1999)(107) Thirty men with non-insulin-
dependent diabetes mellitus
Acute intake Control treatment, 200ml red wine, 150mg tannic acid (equivalent to the content in 200ml
red wine) or 16 g ethanol (equivalent to the content in 200ml red wine)
*When not indicated expressly, grapes are red grapes.
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which is produced by an excessive accumulation of collagen
and is associated with an increase in alterations of cardiac
and vascular functions(41).
Effects on lipid profile
Several studies have focused on the possible positive effects
of grape products on different lipid profile parameters,
particularly total cholesterol, and likewise on LDL- and
HDL-cholesterol, TAG and apolipoproteins. The results of
these trials are summarised in Table 4.
Total cholesterol, LDL-cholesterol and HDL-cholesterol
Nine of the reviewed trials in animals reported a positive
effect of grapes and derived products on plasma total
cholesterol. This was observed after supplementation with
grapes, grape pomace, grape juice, red grape skin, white
grape seed, red and white grape extracts rich in
procyanidins, red wine, red wine polyphenols, dealcoho-
lised red wine or white wine enriched with red wine
polyphenols, to rats fed with a cholesterol-rich diet, to
hamsters (fed with a normal or with an atherogenic diet), to
ovariectomised guinea-pigs or to rabbits(11,13,23,27,58 – 61).
Four similar studies in animals reported no effect on
plasma total cholesterol(26,62 – 64). So, it cannot be said
overall that grapes and derived products present positive
effects on plasma cholesterol in animal studies. However,
one of these studies(26) did find a reduction in cardiac
cholesterol and in the half-times of serum [14C]cholesterol
decay curves, while another reported a decrease in aorta
total cholesterol(63).
As regards studies in human subjects, although a
significant reduction in total cholesterol has been observed,
for example of 12 % after the intake of a grape seed
extract(58) or of 6–11 % after the intake of concentrated
grape juice(24,65), many other studies found no change in
this parameter after the intake of grapes or derived
products(21,25,47,52,66,67).
In the case of LDL-cholesterol, significant reductions
have been observed in studies in both animals(13,27) and in
human subjects(24,29,33,65,68,69), although other studies have
reported no effect either in animals(11,70) or in human
subjects(21,24,47,66,67).
The differences in the results of these assays may have to
do with the design of the study, the polyphenol content of
the tested product or its storage conditions. For example, it
has been noticed that the higher the initial concentration of
plasma cholesterol, the greater the reduction(29,33,69). This
would explain the lack of effects in some of the cited
studies in human subjects, which targeted normocholester-
olaemic subjects. The importance of a proper design can be
seen from the fact that in the studies where some change has
been observed in lipid profile, this change has affected
several parameters(26,64).
The main mechanism responsible for this hypolipidaemic
effect would be reduction in intestinal cholesterol absorp-
tion, leading to an enhanced excretion of faecal neutral
steroids and bile acids. This was first observed by Tebib
et al. (71) in rats supplemented with low- and high-
molecular-weight tannins (a class of polyphenols) from
grapes and was later observed in other assays, for example,
in rats supplemented with a grape seed extract(72). Similarly,
polyphenols would reduce the intestinal absorption of
dietary fat, since it has been observed that both normal and
dealcoholised red wine reduced the postprandial concen-
trations of chylomicrons(73). Also, it has been observed that
polyphenols, in this case from tea, with high molecular
weight (such as tannins present in grapes) form complexes
with bile, which causes disruption of micelles, leading to the
precipitation of cholesterol in the intestinal lumen, which is
a behaviour similar to that of water-soluble dietary fibre(74).
It is also interesting to note that other observed facts
besides changes in plasma total cholesterol may also have a
positive effect on lipid metabolism. For example, after
supplementing of ovariectomised guinea-pigs with freeze-
dried grapes, a positive change was found in the
concentration and composition of LDL particles that were
not readily taken up by the aorta, resulting in less
accumulation of cholesterol in this tissue(11). The authors
of this study also suggested that grapes may reduce the
secretion of LDL particles by the kidney.
As regards HDL-cholesterol, although some studies in
animals have reported positive effects after supplementation
with alcohol-free products(13,27,64), in studies in human
subjects increased HDL-cholesterol has only been observed
once after the intake of red grape juice concentrate by
haemodialysed patients(24), but did not take place in the
trials with alcohol-free grape products(69,75 – 78). Therefore,
this effect is presumably mainly related to the already-
known ability of ethanol to increase HDL-cholesterol(75)
instead of polyphenol content.
Table 4. Summary of observed effects of grapes, wine and derived products on lipid profile in the reviewed studies
Parameter
Trials with
positive effects*
Trials with
neutral effects*
Negative
effects*
Studies on animals Total cholesterol 13, 73, 58–61 26, 62–64
LDL-cholesterol 13, 27 11, 70
HDL-cholesterol 13, 27, 64 61, 62, 70
TAG 11, 13, 72, 86 64
Apolipoproteins 59, 61 60
Studies on human subjects Total cholesterol 24, 29, 58, 65 21, 25, 51, 66, 67 57
LDL-cholesterol 24, 29, 65, 68, 69 21, 25, 32, 47, 65, 66, 69
HDL-cholesterol 69, 75–78 21, 25, 32, 47, 66–68
TAG 29, 68 21, 25, 47, 65–67 19, 56, 80
Apolipoproteins 24, 65, 68 19
*Numbers correspond to references in the Reference section.
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Triacylglycerols
It is known that ethanol can increase plasma TAG(79). One
would therefore expect that if grapes and derived products
had a positive effect on plasma TAG, this would only be so
in the case of alcohol-free products. This tendency was
observed in studies in animals, when supplementation with
freeze-dried grapes, white grape peel, white grape seed,
grape seed polyphenols or dealcoholised red wine to rats,
ovariectomised guinea-pigs or apoE-deficient mice reduced
plasma TAG(11,13,72), while supplementation with wine had
neutral or negative(64) effects on this parameter.
Nevertheless, this aspect was less clear in the case of
human subjects. Although supplementation to menopausal
women with freeze-dried grapes reduced plasma TAG by up
to 15 %(68) and the intake of a grape product rich in both
dietary fibre and polyphenols had a similar effect on
hypercholesterolaemic subjects(29), the intake of other non-
alcoholic grape-derived products had neutral(21,24,47,65) or
negative(56,80) effects. Interestingly, the two tested products
that had a positive effect on this parameter contained
dietary fibre, and that may have contributed significantly to
this effect.
Apolipoproteins
The effects of grapes and derived products on apolipo-
proteins have not been systematically studied. However, the
results of a few trials have shown that the hypolipidaemic
effect of grape polyphenols may be related to their effects on
the concentrations of certain apolipoproteins. For instance,
red wine or red wine polyphenol supplementation to rats
increased apoA1 and reduced apoB(59,61). Similarly, the
same effects were produced by the intake of freeze-dried
grapes or concentrated grape juice by menopausal women or
by healthy and haemodialysed subjects respectively(24,65,68).
Effects on platelet aggregation
Reducing platelet activity is a preventive strategy to reduce
the development of atherosclerosis(23). Several trials have
studied the possible effects of grapes, wine and derived
products on platelet aggregation.
In studies in animals, it has been observed that the intake
of grape juice reduces platelet aggregation induced by
collagen or by ADP as agonists, but not aggregation induced
by phorbol-12-myristate-13-acetate(22,23).
In a trial in rats on the rebound effect on thrombin-
induced platelet aggregation after alcohol withdrawal, it was
observed that 18 h after deprivation of alcohol, 6 % ethanol
increased the platelet response by 124 %, white wine by
46 %, and red wine reduced it by 59 %. This is an interesting
aspect, since the increase in platelet aggregation after
alcohol deprivation is sometimes associated with sudden
death and stroke in humans(12).
The intake of grape juice by human subjects reduced
platelet aggregation induced by collagen, ADP and phorbol-
12-myristate-13-acetate; it also caused an increase in
platelet-derived NO release and a decrease in platelet
superoxide anion production(52,81). The intake of a grape
juice enriched in resveratrol also reduced thrombin-induced
platelet aggregation, but this effect was absent after
supplementation with a commercial grape juice(82).
The intake of red wine and white wine by human subjects
reduced thrombin-induced platelet aggregation and throm-
boxane B2 concentration, but only white wine reduced
ADP-induced aggregation(82).
The suppression of platelet-mediated thrombosis, then, is
another mechanism that could potentially explain the
beneficial effects of grape polyphenols in CVD. Specific
studies should be performed with grape skins, grape seeds,
grape pomace and polyphenols extracted from grapes.
Anti-atherosclerotic effect
Atherosclerosis is a key pathology in CVD, which, once
started, cannot be prevented but may be retarded(83).
Therefore, a great deal of research has focused on the
positive effect that grapes and derived products may have in
preventing the progression of this pathology.
Effects on atheromatous plaque
Several studies have been performed to evaluate the effect of
supplementation with grape polyphenols in the development
of atherosclerotic lesions. Due to the nature of the
measurements performed, they can only be developed in
animals.
A significant reduction in the size of atherosclerotic
lesions or in the accumulation of foam cells in aorta has been
observed after supplementation with red wine, deal-
coholised red wine, red wine polyphenols, white wine
enriched in polyphenols, and white and red grape extracts to
apoE-deficient mice and hamsters with an atherogenic diet
and to rabbits and Watanabe heritable hyperlipidaemic
rabbits(58,61,63,83,84). Also, red wine or dealcoholised red
wine supplementation to rats induced a marked pro-
longation of template bleeding time, a decrease in platelet
adhesion to fibrillar collagen and a reduction in thrombus
weight, while neither ethanol nor white wine affected these
systems(50).
These studies found that there was an effect mainly in the
early stages of atherosclerosis, during fatty streak
formation. In contrast, another study that examined the
mature phase of atherosclerosis reported no positive effects
in terms of the speed of progression of the lesions, inhibition
in the aortic root and brachicephalic trunk or changes in
collagen content of atheromatous plaques after red wine
powder supplementation to apoE-deficient mice(85).
Similarly, Stocker & O’Halloran(86) found a reduction in
the aortic lesions in the aortic arch, but not in the aortic root
after supplementing apoE-deficient mice with dealcoholised
red wine. Since lesions in the aortic root are more developed
than in the aortic arch, this may confirm that grape
polyphenols are only able to inhibit atherosclerosis during
its early stages, although this would be an important
beneficial effect in any case.
Anti-atherosclerotic and hypolipidaemic effects were
considered separately in a study on hamsters supplemented
with red wine or dealcoholised red wine(58); it was observed
that the polyphenols present in these products exhibited an
anti-atherosclerotic effect over and above their effects on the
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lipid profile. Also, these effects on the development of
atheromatous plaque were presumably due not only to their
antioxidant effects, but also to inhibition of cell proliferation
in smooth muscle, regulation of adhesion molecules and
reduction of the flux of atherogenic molecules from the
endothelium to the arterial wall(52,53).
To the authors’ knowledge, studies in animals have not
specifically addressed the possible atherosclerotic effect of
grape skins and grape seeds.
Although many of these assays cannot be performed on
human subjects, some studies have examined the effect of
wine intake on monocyte–endothelial cell adhesion, an early
event in atheromatous plaque formation. Results show that
white and red wine intakes reduced monocyte adhesion to
TNF-a-stimulated endothelial cells by 51 and 89–96 %
respectively(16,17). Since the effect achieved by gin was 39 %,
the polyphenols present in wine presumably contributed
significantly to this effect, which may be the result of down-
regulation of some monocyte adhesion molecules, especially
very light-appearing antigen 4, on the monocyte surface.
Effects on LDL oxidation
The oxidative hypothesis of atherosclerosis suggests that
LDL oxidation could be a first step in the development of
atheromatous plaque. For instance, several studies have
considered the effects of grape polyphenols on different
parameters related to LDL oxidation.
A decrease in the concentration of oxidised LDL or an
increase in the lag-phase in the oxidation of LDL has been
observed after red wine or grape supplementation to apoE-
deficient mice or to cholesterol-fed rabbits(63,70,85). Inter-
estingly, supplementation with wine polyphenols in ethanol
to rats reduced LDL oxidation, but polyphenols in water had
no effect and ethanol alone increased it, indicating a
possible contribution of ethanol to the metabolism of
polyphenols(87).
In studies in human subjects, the intake of red wine, red
wine polyphenols, white wine enriched with red wine
polyphenols, grape juice or concentrated grape juice by
healthy subjects or haemodialysed patients had positive
effects on LDL oxidation(21,65,77,78,80,88). The effect of
supplementation to human subjects with grape pomace on
this parameter has not been considered.
However, other similar studies reported no such
effects(25,33). It is interesting that in one of these studies(47),
the authors explained that the storage conditions of the
tested product had not been the same as in a previous one
where they had observed a decrease in LDL oxidation. This
shows the importance of storage conditions for polyphenol-
rich products, since it is well known that the antioxidant
capacity of polyphenol-rich products decreases during
storage at room temperature.
Castilla et al. (65) looked for a possible correlation between
oxidised LDL and LDL concentration after the intake of
grape juice by human subjects for 4 weeks; they did not find
any, which suggests that besides a reduction in total LDL
(the hypolipidaemic effect of polyphenols noted earlier),
there may be other mechanisms – mainly antioxidants – that
would explain the reduction in oxidised LDL.
Effects on inflammation markers
Inflammation and CVD are closely linked, since oxidised
LDL are taken up by monocytes, starting the process that
produces the foam cells characteristic of the onset of
atherosclerosis.
Supplementation to apoE-deficient mice did not
modify the levels of monocyte chemo-attractant protein 1
(MCP-1)(84). However, studies in human subjects have
mainly reported positive results regarding these parameters.
The intake of red wine, but not of alcohol, reduced
the expression of lymphocyte function-associated antigen
1, Mac-1, very light-appearing antigen 4 and MCP-1 in
monocytes, and also the expression of vascular cellular
adhesion molecule 1 and intercellular adhesion molecule 1
and the concentration of fibrinogen in lymphocytes(17,78,89).
Interestingly, one of these studies(17) reported these results
in women who were supplemented with 20 g ethanol per d;
although women’s threshold of moderate ethanol consump-
tion is lower than that of men, this dose was associated with
beneficial effects in inflammation markers similar to those
observed in men consuming doses of 30 g/d. Also, the intake
of concentrated red grape juice by patients affected by end-
stage renal disease treated with haemodialysis (with an
increased oxidative stress) led to a reduction in plasma
concentrations of MCP-1 and of NADH oxidase activity, a
main source of superoxide radicals(24).
A significant increase was reported in IL-6 at 6 h after the
intake of a meal accompanied by red or white wine, greater
than the increase observed when the meal was accompanied
by a control beverage(20). The authors suggested that this
increase was due more to a response to the hepatic damage
induced by alcohol than to an activation of the inflammation
response, since there was no change in the levels of cell
adhesion molecules. Moreover, this increase in plasma IL-6
did not prevent a substantial improvement in endothelial
function with wine intake.
However, other biomarkers have been proposed as being
better suited to study the relationship between inflammation
and CVD than cell adhesion molecules, specific cytokines or
fibrinogen, which may be associated with any kind of
inflammatory situation. The most important of these
biomarkers are C-reactive protein and homocysteine(90,91).
A significant decrease in C-reactive protein has been
observed after the intake of red wine(78,89), but not of freeze-
dried grapes(68). These studies did not express the content of
polyphenols of the tested samples in the same way, which
makes difficult a direct comparison between the results and
to arrive at a possible explanation of the different effects
observed. This disparity in the expression of polyphenol
content is common in the reviewed trials and is a severe
drawback when trying to compare them.
The results on homocysteine have also been contra-
dictory; a non-significant decrease has been observed after
the intake of red wine(77), while other studies have reported
a significant undesired increase(92). However, in this trial the
subjects drank four glasses of wine daily, which is more than
what is usually considered moderate.
In any event there is a need for more studies on the effects
of grapes and derived products (particularly grape skins and
grape seeds, products on which no study has been developed
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in relation to inflammation) on inflammation markers,
particularly C-reactive protein and homocysteine.
Effects on oxidative stress
There is a close link between a prolonged situation of
oxidative stress and CVD, and dietary antioxidants may play
a role in the prevention of the overproduction of free
radicals. There are several ways to evaluate in vivo
antioxidant status, including measurements of plasma
antioxidant capacity, oxidation biomarkers, antioxidant
compounds and evaluation of the activity of hepatic
enzymes. Table 5 summarises the results of the trials
reviewed in these parameters. It is interesting to note that the
effect of all the grape-derived products considered in the
present review on oxidative stress has been tested using
more than one of the different common ways to evaluate it.
Plasma antioxidant capacity
The antioxidant capacity of plasma has been measured in
different grapes and derived product supplementation
studies in animals. An increase in the ferric-reducing
antioxidant power value was observed in several studies
after the intake of red wine or dealcoholised red wine by
rats; the increase was greater with red wine(64,93). Similarly,
the intake of grape polyphenols by hamsters increased
plasma antioxidant capacity measured by 2,20-azino-bis(3-
ethylbenz-thiazoline-6-sulfonic acid); this increase was
greater when polyphenols were dissolved in ethanol than
when they were dissolved in water(59). These results suggest
that the bioavailability of polyphenols is enhanced in
ethanol media, and hence in wine.
It has also been reported that there was an increase in the
antioxidant capacity of rat and chicken faeces after
supplementation with a grape product rich in both dietary
fibre and polyphenols, and an increase in the excretion of
polyphenols, particularly proanthocyanidins(94 – 96).
However, other authors have obtained results that
contradict these. For example, one study found that the
intake of red wine by apoE-deficient mice did not modify
plasma antioxidant capacity(85). The same happened after
supplementation to hamsters with different extracts from
grapes(52) or to rats with grape pomace. In this last case,
there was actually a significant loss of antioxidant capacity
in the liver(26). These differences in results of similar assays
may be related to the various limitations that have been
reported in the determination of plasma antioxidant
capacity(97), as well as to differences in the designs of the
studies (duration of treatment, doses employed).
In the case of human subjects, although some studies
reported no effect on plasma antioxidant capacity after
supplementation with grape-derived products(98), most of the
trials did find some effect; for instance, increased plasma
antioxidant capacity was observed after the intake of
polyphenol extracts from red wine(32), from grapes(33),
grape juice(65), concentrated grape juice(80), grape
pomace(99) and red wine(77).
Also, studies on the possible effect of grape polyphenols
in the postprandial phase have reported that after a meal
accompanied by red wine, plasma antioxidant capacity by
the total radical-trapping antioxidant parameter assay was
sustained in type 2 diabetic subjects, whereas after the same
meal without wine there was a significant decrease in
antioxidant capacity(100).
A correlation was found between plasma antioxidant
capacity and plasma cholesterol and TAG(85,100). This is
quite surprising, since subjects with higher plasma lipids
and hence a higher risk of CVD would be expected to have
lower values of plasma antioxidant capacity. This aspect
requires further study, since it could be related to the
transport of polyphenols within the bloodstream, a process
that is not yet fully understood.
Oxidation biomarkers
Oxidation biomarkers are molecules that are directly
affected by the oxidation process and hence furnish a
more specific measurement of oxidative status.
Malondialdehyde (MDA) is a biomarker of lipid
oxidation. The MDA concentration decreased in plasma,
liver and kidney of rats supplemented with red wine for
6 months; in the group supplemented only with ethanol,
MDA decreased in plasma in response to a higher
consumption of vitamin E(101). Similarly, freeze-dried
grape supplementation to rats reduced MDA concentration
in the heart(10), polyphenol-enriched red wine and white
wine supplementation to hamsters reduced plasma MDA(61),
and red wine and dealcoholised red wine supplementation to
rats reduced the concentration of MDA in the renal cortex
and renal papilla(93). Grape extract supplementation to
rabbits did not modify plasma MDA levels but did modify
levels in the aorta(63). Also, a reduction of MDA has been
reported in breast and thigh meat from chicken sup-
plemented with concentrated grape pomace(95,96).
Thiobarbituric acid-reactive substances (TBARS) are
another marker of lipid oxidation, although less specific.
Table 5. Summary of observed effects of grapes, wine and derived products on oxidative stress
Measurements Positive effects† Neutral effects†
Studies on animals Plasma antioxidant capacity 59, 64, 93, 94 26*, 60, 85
Biomarkers of oxidation 46, 61–63, 72, 88, 105 70
Antioxidant compounds 62 86
Antioxidant enzymes 26, 93, 101 26*
Studies on human subjects Plasma antioxidant capacity 22, 32, 52, 65, 77, 80, 99 98
Biomarkers of oxidation 21, 67, 68, 80, 98 25, 46, 80, 84
Antioxidant compounds 21, 32, 65, 67, 77, 88, 98 25, 67
*Negative effects.
†Numbers correspond to refernces in the Reference section.
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A decrease in the velocity of generation of TBARS was
observed after supplementing rats with wine or with
ethanol(62). Similarly, grape seed polyphenol supplemen-
tation to rats reduced this marker by 33 %(72). However, red
wine supplementation did not modify this value in apoE-
deficient mice(70).
In human studies, TBARS were reduced after the intake
of white wine, white wine enriched with polyphenols and
red wine polyphenols(88), although De Rijke et al. (25)
reported no effect on this value after the intake of white
or red wine. These differences may be due to the dose of
polyphenols administered in each case; in the case of
De Rijke et al. (25), the subjects drank more wine than
in Nidgikar et al. (88) (550 v. 375 ml/d), but different
polyphenol contents may have affected the results. It is not
possible to determine this, since Nidgikar et al. (88) reported
the total polyphenol content while De Rijke et al. (25)
determined the content of only some particular polyphenols
(catechins, quercetin, etc) in the wines tested, by HPLC.
Many of the reviewed trials express the polyphenol contents
in the tested substances differently, which makes it difficult
to compare them directly.
Another suggested marker of lipid oxidation is
F2-isoprostanes, although the results reported by different
authors for this marker have been contradictory. It has been
reported that there was a significant decrease in plasma and
urine isoprostanes after the intake of red wine by male
smokers(67), of freeze-dried grapes by pre- and postmeno-
pausal women(68) and of white and red wine by healthy
subjects(21). Nevertheless, Waddington et al. (84) found no
change in plasma isoprostanes or in hydroxyeicosatrenoic
acids after red wine supplementation to apoE-deficient
mice. Similarly, there was no change in this biomarker after
the intake of concentrated grape juice(80) or grape seed
polyphenols(46) by human subjects. Once again, these
differences may be due to the different doses employed or to
the phenolic composition of the tested products.
In contrast, biomarkers of protein and DNA oxidation
have proven to be useful tools for evaluating the effect of
supplementation with grape-derived products, and although
not many studies have used them, the results tend to agree.
A decrease in protein oxidation has been observed after
polyphenol-enriched red wine and white wine supplemen-
tation to hamsters with an atherogenic diet(61) and after
concentrated grape juice supplementation to human
subjects(80). As regards DNA, a decrease in damage to
neuronal DNA was observed after supplementing gerbils
with freeze-dried grapes(102). In trials in human subjects,
there was a decrease in the 8-oxo-deoxygunaosin:de-
oxiguanosin ratio after the intake of procyanidins from
grape seeds, sustained for 1 week after cessation of the
treatment(98), and after supplementation with red wine to
patients with acute coronary syndrome(103).
Measurement of antioxidant compounds
Several studies have dealt with the evolution of plasma
polyphenols after the intake of grapes and derived products.
The bioavailability of dietary polyphenols has been
reviewed elsewhere(104,105), so we will only refer here to
observations after chronic and not after acute intakes, which
have tended to produce positive results. Plasma polyphenols
increased after the intake of red wine, polyphenol-enriched
white wine or red wine polyphenols(15,21,88). Similarly, an
increase was observed in the urinary excretion of 4-o-
methyl-gallic acid after the consumption of red wine and
dealcoholised red wine(67), in the urinary excretion of four
metabolites from flavan-3-ols after the intake of red wine(77)
and in the urinary excretion of resveratrol metabolites after
the intake of red and white wine(17).
Vitamins C and E are plasma constituents that exhibit
antioxidant capacity and whose plasma concentrations may
be affected by polyphenol metabolism. Because of this,
some intervention studies with antioxidants have evaluated
the evolution of the concentration of these compounds.
In studies in animals, the intake of red wine and ethanol
caused a significant increase in plasma vitamin C(62) in rats,
and concentrated grape pomace supplementation increased
liver vitamin E(95) in chickens, while dealcoholised red wine
supplementation did not modify plasma levels of vitamins C
and E in apoE-deficient hamsters(86).
In the case of human subjects, no modification in plasma
antioxidant vitamin concentrations has been observed after
the intake of white wine, red wine, dealcoholised red wine
or grape procyanidins(25,67,98). However, some interesting
observations regarding vitamin E should be noted: the
intake of red wine polyphenols increased vitamin E content
in LDL by 15 %(32); the intake of grape procyanidins did not
modify vitamin E levels in plasma, but did increase them in
erythrocytes(98); although there was no increase in plasma
vitamin C after the intake of concentrated grape juice, when
its concentration was normalised dividing it between plasma
cholesterol, there was a significant increase due to the
treatment(65). These data show that grape polyphenols do
not have the same effect on the plasma levels of vitamin C
and of vitamin E, and also that in the latter case polyphenols
would contribute to its regeneration, as noted earlier(106).
Hepatic enzymes
Aerobic organisms possess enzymic systems that counteract
the effect of free radicals. The activity of these systems may
be reduced as a consequence of stress situations, and
increased after the intake of polyphenol-rich products. Some
trials on animals to determine the effects of grapes and
derived products have measured the activity of these
enzymes.
Roig et al. (101) observed an increase in the activities of
superoxide dismutase and glutathione peroxidase in rats
45 d after supplementation with red wine; however, this was
not sustained over 6 months of intake, at the end of which a
reduction was observed in the levels of MDA in plasma and
other tissues. The authors concluded that the intake of red
wine initially activated antioxidant enzymes, but the long-
term effect was to reduce lipid peroxidation. Similarly, red
wine and ethanol supplementation caused an increase in the
activities of glutathione peroxidase in the renal cortex and
renal papilla of rats(93). Also, an increase in hepatic
glutathione peroxidase activity after the intake of grape
pomace by rats was observed, although there was no change
in any of the other hepatic enzymes, and there was a
significant decrease in the activities of these enzymes in the
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erythrocytes. A similar tendency was observed for tomato
and apple pomace(26).
Effects on glycaemia
In a trial in fructose-fed rats, a model of insulin resistance
without obesity, when the rats were supplemented with
grape polyphenols, there was no change in plasma glucose
or insulin, but there was a significant reduction in the
homeostasis model assessment of insulin resistance
(HOMA:ir) index, which measures insulin resistance(43).
As regards studies in human subjects, some trials have
produced positive results. In those that reported no effect,
this may be related to the design of the study. Williams
et al. (20) observed a decrease in plasma glucose 6 h after
intake of red wine or white wine by coronary artery disease
patients, and Gin et al. (107) reported that maximum glucose
excursion after an acute intake of red wine or tannic acid
(phenolic present in red wine) was significantly lower than
after the intake of water or ethanol alone.
Two trials reported no effect on plasma glucose, insulin,
insulin sensitivity or HOMA:ir after supplementation with
red wine or dealcoholised red wine(66,69). However, one
of these studies was performed in moderately obese
women(66); the authors discussed the possibility of an
interaction between the alcohol dose and the body
composition that could have masked potential beneficial
changes in insulin sensitivity, since it is known that the
metabolic response of overweight subjects, in terms of
glycaemia and insulin sensitivity, differs from the response
of normal-weight subjects(107).
Other authors have suggested that, although polyphenols
do not have a direct effect on postprandial glycaemia, they
may affect other related parameters. For instance, Ceriello
et al. (100) found no difference in plasma glucose in type 2
diabetic patients after a meal accompanied by red wine as
compared with a control group. Nevertheless, this study
found that the intake of wine had a beneficial effect on
postprandial oxidative stress, a key step in the generation of
free radicals in diabetic patients(98).
Conclusions
From the in vivo studies performed during the last 13 years
addressing the effects of grape products on different
parameters related to CVD that were reviewed, the
following effects have been observed:
(1) A hypotensive effect, observed in several studies in
animals and in human subjects, mainly due to an
increase in the release of NO.
(2) A hypolipidaemic effect, reducing levels of plasma
total cholesterol, LDL-cholesterol and TAG. The
results in human subjects suggest that these effects
are more pronounced the higher the plasma lipids at
baseline are. The hypolipidaemic effect of polyphenols
would be related to the fact that these compounds may
absorb cholesterol, bile acids and other dietary lipids
and increase their faecal excretion.
(3) An anti-atherosclerotic effect in the early stages of
development of atherosclerosis, observed as a
reduction in atheromatous plaque and in LDL
oxidation. This effect appears to be due to the
inhibition of cell proliferation in smooth muscle and
to antioxidant protection of LDL.
(4) An improvement in antioxidant status measured in
terms of plasma antioxidant capacity, oxidation
biomarkers, antioxidant compounds and antioxidant
enzymes.
The presence of dietary fibre in some of the tested
products may enhance some of the above effects.
Differences in the design of the studies and in the
composition of the tested products (not always provided)
can explain the different results produced by some of these
assays. The relative contribution of major constituents such
as polyphenols, ethanol and dietary fibre remains to be
elucidated.
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